Gamma interferon stimulates rat alveolar macrophages to kill Pneumocystis carinii by L-arginine- and tumor necrosis factor-dependent mechanisms

Infection and Immunity

Volumn 67, Issue 3, 1999, Pages 1347-1352

  Downing, James F ^a,c   Kachel, Diane L ^a   Pasula, Rajamouli ^a   Martin II, William J ^a,b  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

^b OPW 425   (United States)

^c Indiana Nephrology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GAMMA INTERFERON; NITRITE; NITROGEN OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BACTERICIDAL ACTIVITY; CELL VIABILITY; CONCENTRATION RESPONSE; CYTOKINE PRODUCTION; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; IMMUNOPRECIPITATION; LUNG ALVEOLUS MACROPHAGE; NONHUMAN; PNEUMOCYSTIS CARINII; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RAT; TIME;

EID: 0032976528     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.3.1347-1352.1999     Document Type: Article

References (51)

1. Adams, D. 1980. Effector mechanisms of cytolytically activated macrophages. I. Secretion of neutral proteases and the effect of protease inhibitors. J. Immunol. 124:286-292.
2. Adams, D., K. Kao, R. Farb, and S. Pizzo. 1980. Effector mechanisms of cytolytically activated macrophages. II. Secretion of a cytolytic factor by activated macrophages and its relationship to secreted neutral proteases. J. Immunol. 124:293-300.
3. Babior, B. M. 1978. Oxygen-dependent microbial killing by phagocytes (two parts). N. Engl. J. Med. 298:559-668; 721-725.
4. Bartlett, M. S., J. A. Fishman, S. F. Queener, M. M. Durkin, M. A. Jay, and J. W. Smith. 1988. New rat model of Pneumocystis carinii pneumonia. J. Clin. Microbiol. 26:1100-1102.
5. Beck, J. M., H. D. Liggitt, E. N. Brunette, H. J. Fuchs, J. E. Shellito, and R. J. Debs. 1991. Reduction in intensity of Pneumocystis carinii pneumonia in mice by aerosol administration of gamma interferon. Infect. Immun. 59:3859-3862.
6. Benfield, T., B. Lundgren, S. Levine, G. Kronborg, J. Shelhamer, and J. Lundgren. 1997. The major surface glycoprotein of Pneumocystis carinii induces release and gene expression of interleukin-8 and tumor necrosis factor alpha in monocytes. Infect. Immun. 65:4790-4794.
7. Chen, W., E. A. Havell, and A. G. Harmsen. 1992. Importance of endogenous tumor necrosis factor alpha and gamma interferon in host resistance against Pneumocystis carinii infection. Infect. Immun. 60:1279-1284.
8. Corsini, E., C. Dykstra, W. A. Craig, R. R. Tidwell, and G. J. Rosenthal. 1992. Pneumocystis carinii induction of tumor necrosis factor-alpha by alveolar macrophages: modulation by pentamidine isethionate. Immunology 34: 303-308.
9. Decker, T., M. L. Lohmann-Matthes, and G. E. Gifford. 1987. Cell-associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages. J. Immunol. 138:957-962.
10. Ding, A. H., C. F. Nathan, and D. J. Stuehr. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J. Immunol. 141:2407-2413.
11. Dorman, S. E., and S. M. Holland. 1998. Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. J. Clin. Invest. 101:2364-2369.
12. Eales, L. J., O. Moshtael, and A. J. Pinching. 1987. Microbicidal activity of monocyte derived macrophages in AIDS and related disorders. Clin. Exp. Immunol. 67:227-235.
13. Fauci, A. S. 1984. Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic, and therapeutic considerations. Ann. Intern. Med. 100:92-106.
14. Frankova, D., and Z. Zidek. 1998. IFN-gamma-induced TNF-alpha is a prerequisite for in vitro production of nitric oxide generated in murine peritoneal macrophages by IFN-gamma. Eur. J. Immunol. 28:838-843.
15. Friedman, Y., C. Franklin, S. Freels, and M. H. Weil. 1991. Long-term survival of patients with AIDS. Pneumocystis carinii pneumonia, and respiratory failure. JAMA 266:89-92.
16. Hanano, R., K. Reifenberg, and S. Kaufmann. 1998. Activated pulmonary macrophages are insufficient for resistance against Pneumocystis carinii. Infect. Immun. 66:305-314.
17. Hibbs, J., Jr., R. Taintor, Z. Vavrin, and E. Rachlin. 1988. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem. Biophys. Res. Commun. 157:87-94.
18. Hibbs, J. B., Jr., R. R. Taintor, and Z. Vavrin. 1987. Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrate. Science 235:473-476.
19. Ichinose, Y., O. Bakouche, J. Tsao, and I. Fidler. 1988. Tumor necrosis factor and IL-1 associated with plasma membranes of activated human monocytes lyse monokine-sensitive but not monokine resistant tumor cells whereas viable activated monocytes lyse both. J. Immunol. 141:512-518.
20. Kobzik, L., D. Bredt, C. Lowenstein, J. Drazen, B. Gaston, D. Sugarbaker, and J. Stamler. 1993. Nitric oxide synthase in human and rat lung: immunocytochemical and immunocytochemical localization. Am. J. Respir. Cell Mol. Biol. 9:371-377.
21. Kolls, J., J. M. Beck, S. Nelson, W. R. Summer, and J. Shellito. 1993. Alveolar macrophage release of tumor necrosis factor during murine Pneumocystis carinii pneumonia. Am. J. Respir. Cell Mol. Biol. 8:370-376.
22. Kolls, J. K., D. Lei, C. Vazquez, G. Odom, W. R. Summer, S. Nelson, and J. Shellito. 1997. Exacerbation of murine Pneumocystis carinii infection by adenoviral-mediated gene transfer of a TNF inhibitor. Am. J. Respir. Cell Mol. Biol. 16:112-118.
23. Levitz, S. 1994. Macrophage-cryptococcus interactions. Immunol. Ser. 60: 533.
24. Limper, A. H., J. S. Hoyte, and J. E. Standing. 1997. The role of alveolar macrophages on Pneumocystis carinii degradation and clearance from the lung. J. Clin. Invest. 99:2110-2117.
25. Limper, A. H., K. P. Offord, T. F. Smith, and W. J. Martin II. 1989. Pneumocystis carinii pneumonia: differences in lung parasite number and inflammation in patients with and without AIDS. Am. Rev. Respir. Dis. 140:1204-1209.
26. Lin, J.-Y., R. Seguin, K. Keller, and K. Chadee. 1994. Tumor necrosis factor alpha augments nitric oxide-dependent macrophage cytotoxicity against Entamoeba histolytica by enhanced expression of the nitric oxide synthase gene. Infect. Immun. 62:1534-1541.
27. Martin, W. J., II, and D. L. Kachel. 1987. Bleomycin-induced pulmonary endothelial cell injury: protection by the iron chelator deferoxamine, but not EDTA. J. Lab. Clin. Med. 110:153-158.
28. Martinez, A., and J. Kovacs. 1993. Development and characterization of a rapid screening assay for identifying antipneumocystis agents. Antimicrob. Agents Chemother. 37:1674-1678.
29. Masur, H., and T. C. Jones. 1978. The interaction in vitro of Pneumocystis carinii with macrophages and L-cells. J. Exp. Med. 147:157-170.
30. Meltzer, M. 1981. Macrophage activation for tumor cytotoxicity: characterization of priming and trigger signals during lymphokine activation. J. Immunol. 127:179-183.
31. Milstien, S., N. Sakai, S. Kaufman, K. Saito, and M. Heyes. 1993. Role of tetrahydrobiopterin in cytokine-stimulated metabolism of tryptophan and hydroxylation of arginine. Adv. Exp. Med. Biol. 338:289-294.
32. Murray, H. W., R. A. Gellene, D. M. Libby, C. D. Rothermel, and B. Y. Rubin. 1985. Activation of tissue macrophages from AIDS patients: in vitro response of AIDS alveolar macrophages to lymphokines and interferon-gamma. J. Immunol. 135:2374-2377.
33. Murray, H. W., B. Y. Rubin, H. Masur, and R. B. Roberts. 1984. Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome. N. Engl. J. Med. 310:883-889.
34. Murray, J., and J. Mills. 1990. Pulmonary infectious complications of human immunodeficiency virus infection (part II). Am. Rev. Respir. Dis. 141:1582-1598.
35. Nicholson, S., M. D. G. Bonecini-Almida, J. Lapa e Silva, C. Nathan, Q. Xie, R. Mumford, J. Weidner, J. Calaycay, J. Geng, N. Boechat, C. Linhares, W. Tom, and J. Ho. 1996. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J. Exp. Med. 183:2293-2302.
36. Padgett, E. L., and S. B. Pruett. 1992. Evaluation of nitrite production by human monocyte-derived macrophages. Biochem. Biophys. Res. Commun. 186:775-781.
37. Pesanti, E. L. 1989. Interaction of cytokines and alveolar cells with Pneumocystis carinii in vitro. J. Infect. Dis. 163:611-616.
38. Pottratz, S. T., and W. J. Martin II. 1990. Mechanism of Pneumocystis carinii attachment to cultured rat alveolar macrophages. J. Clin. Invest. 86:1678-1683.
39. Pottratz, S. T., and W. J. Martin II. 1990. Role of fibronectin in Pneumocystis carinii attachment to cultured lung cells. J. Clin. Invest. 85:351-356.
40. Sattler, F. R., R. Cowan, D. M. Nielsen, and J. Ruskin. 1988. Trimethoprim-sulfamethoxazole compared with pentamidine for the treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: a prospective non-crossover study. Ann. Intern. Med. 107:280-287.
41. Shear, H. L., G. Valladares, and M. A. Narachi. 1990. Enhanced treatment of Pneumocystis carinii pneumonia in rats with interferon-γ and reduced doses of trimethoprim/sulfamethoxazole. J. Acquired Immune Defic. Syndr. 3:943-948.
42. Shellito, J., V. V. Suzara, W. Blumenfeld, J. M. Beck, H. J. Steger, and T. H. Ermak. 1990. A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes. J. Clin. Invest. 85:1686-1693.
43. Shellito, J. E., J. K. Kolls, R. Olariu, and J. Beck. 1996. Nitric oxide and host defense against Pneumocystis carinii infection in a mouse model. J. Infect. Dis. 173:432-439.
44. Sherman, M. P., M. L. Loro, V. Z. Wong, and D. P. Tashkin. 1991. Cytokine- and Pneumocystis carinii-induced L-arginine oxidation by murine and human pulmonary alveolar macrophages. J. Protozool. 38:234S-236S.
45. Simonpoli, M., P. Rajagopalan-Levasseur, M. Brun-Pascaud, G. Bertrand, M. Pocidalo, and P. Girard. 1996. Influence of Pneumocystis carinii on nitrite production by rat alveolar macrophages. J. Eukaryot. Microbiol. 43:400-403.
46. Stuehr, D., and C. Nathan. 1989. Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 169:1543-1555.
47. Sung, C., R. Dedrick, W. Hall, P. Johnson, and R. Youle. 1993. The spatial distribution of immunotoxins in solid tumors: assessment by quantitative autoradiography. Cancer Res. 53:2092-2099.
48. Torrico, F., H. Heremans, M. T. Rivera, E. Van Marck, A. Billiau, and Y. Carlier. 1991. Endogenous IFN-γ is required for resistance to acute Trypanosoma cruzi infection in mice. J. Immunol. 146:3626-3632.
49. Von Behren, L. A., and E. L. Pesanti. 1978. Uptake and degradation of Pneumocystis carinii by macrophages in vitro. Am. Rev. Respir. Dis. 118: 1051-1059.
50. Williams, M. D., J. R. Wright, K. L. March, J. Downing, and W. J. Martin II. 1996. Human surfactant protein A enhances attachment of Pneumocystis carinii to rat alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 14:232-238.
51. Wright, T., C. Johnston, A. Harmsen, and J. Finelstein. 1997. Analysis of cytokine mRNA profiles in the lungs of Pneumocystis carinii-infected mice. Am. J. Respir. Cell Mol. Biol. 17:491-500.